Best in 7 days FOXO4 -DRI (10MG)INJECTION, Packaging Type: Vial at ₹ 3200/piece in Nagpur US$ 29.23 Sold : Login>>
Best in 7 days FOXO4-DRI: A Breakthrough Peptide Targeting Aging at Its Roots US$ 24.63 Sold : Login>>
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial US$ 28.42 Min. order: 1 piece ★★★★★ 4.6 (46 reviews) Sold : Login>>
GHK-Cu Dosage and Protocol: A Medical Provider's Guide to the 30-Day Cycle US$ 23.79 Min. order: 1 piece ★★★★★ 4.5 (35 reviews) Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.02 Min. order: 1 piece ★★★★★ 4.4 (155 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 27.88 Min. order: 1 piece ★★★★★ 4.1 (222 reviews) Sold : Login>>
NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity — TradingView News US$ 21.73 Min. order: 1 piece ★★★★★ 4.4 (290 reviews) Sold : Login>>
Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 US$ 25.51 Min. order: 1 piece ★★★★★ 5.0 (140 reviews) Sold : Login>>